199 related articles for article (PubMed ID: 33414585)
1. I. How can you choose the fate of iPSCs and stem cells, Regeneration or Carcinogenesis? A hypothetical insight.: II. Modelling human beta cell development with pluripotent stem cells.
Seno M; Nostro MC
J Stem Cells Regen Med; 2020; 16(2):90-91. PubMed ID: 33414585
[TBL] [Abstract][Full Text] [Related]
2. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
4. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
Cierpka-Kmiec K; Wronska A; Kmiec Z
Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
[TBL] [Abstract][Full Text] [Related]
5. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells.
Zhu FF; Zhang PB; Zhang DH; Sui X; Yin M; Xiang TT; Shi Y; Ding MX; Deng H
Diabetologia; 2011 Sep; 54(9):2325-36. PubMed ID: 21755313
[TBL] [Abstract][Full Text] [Related]
6. Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo.
Pellegrini S; Ungaro F; Mercalli A; Melzi R; Sebastiani G; Dotta F; Broccoli V; Piemonti L; Sordi V
Acta Diabetol; 2015 Dec; 52(6):1025-35. PubMed ID: 25733399
[TBL] [Abstract][Full Text] [Related]
7. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells.
Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H
J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181
[TBL] [Abstract][Full Text] [Related]
8. Microporous Polymer Scaffolds for the Transplantation of Embryonic Stem Cell Derived Pancreatic Progenitors to a Clinically Translatable Site for the Treatment of Type I Diabetes.
Kasputis T; Clough D; Noto F; Rychel K; Dye B; Shea LD
ACS Biomater Sci Eng; 2018 May; 4(5):1770-1778. PubMed ID: 30345348
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Differentiation of Pluripotent Stem Cells into Functional β Islets Under 2D and 3D Culture Conditions and In Vivo Preclinical Validation of 3D Islets.
Bose B; Sudheer PS
Methods Mol Biol; 2016; 1341():257-84. PubMed ID: 25783769
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Differentiation of Stem Cell-derived Human Pancreatic Progenitors to Treat Type 1 Diabetes.
Maloy MH; Ferrer MA; Parashurama N
Stem Cell Rev Rep; 2020 Dec; 16(6):1139-1155. PubMed ID: 32844324
[TBL] [Abstract][Full Text] [Related]
11. Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control.
Kim MJ; Lee EY; You YH; Yang HK; Yoon KH; Kim JW
Stem Cell Res; 2020 Oct; 48():101958. PubMed ID: 32882526
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus.
Agrawal A; Narayan G; Gogoi R; Thummer RP
Adv Exp Med Biol; 2021; 1347():1-27. PubMed ID: 34426962
[TBL] [Abstract][Full Text] [Related]
13. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
[TBL] [Abstract][Full Text] [Related]
14. Generation of Pancreatic β-cells From iPSCs and their Potential for Type 1 Diabetes Mellitus Replacement Therapy and Modelling.
Csobonyeiova M; Polak S; Danisovic L
Exp Clin Endocrinol Diabetes; 2020 May; 128(5):339-346. PubMed ID: 30114722
[TBL] [Abstract][Full Text] [Related]
15. [Transplantation in diabetes type 1--current problems and perspectives].
Wasikowa R; Noczyńska A; Basiak A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):119-22. PubMed ID: 15504315
[TBL] [Abstract][Full Text] [Related]
16. Highly efficient methods to obtain homogeneous dorsal neural progenitor cells from human and mouse embryonic stem cells and induced pluripotent stem cells.
Zhang M; Ngo J; Pirozzi F; Sun YP; Wynshaw-Boris A
Stem Cell Res Ther; 2018 Mar; 9(1):67. PubMed ID: 29544541
[TBL] [Abstract][Full Text] [Related]
17. Insulin-producing cells derived from stem cells: recent progress and future directions.
Santana A; Enseñat-Waser R; Arribas MI; Reig JA; Roche E
J Cell Mol Med; 2006; 10(4):866-83. PubMed ID: 17125591
[TBL] [Abstract][Full Text] [Related]
18. Nanotopographical regulation of pancreatic islet-like cluster formation from human pluripotent stem cells using a gradient-pattern chip.
Kim JH; Park BG; Kim SK; Lee DH; Lee GG; Kim DH; Choi BO; Lee KB; Kim JH
Acta Biomater; 2019 Sep; 95():337-347. PubMed ID: 30529081
[TBL] [Abstract][Full Text] [Related]
19. Kidney regeneration from human induced pluripotent stem cells.
Mae S; Osafune K
Curr Opin Organ Transplant; 2015 Apr; 20(2):171-7. PubMed ID: 25856179
[TBL] [Abstract][Full Text] [Related]
20. Metabolic switching, growth kinetics and cell yields in the scalable manufacture of stem cell-derived insulin-producing cells.
Iworima DG; Baker RK; Ellis C; Sherwood C; Zhan L; Rezania A; Piret JM; Kieffer TJ
Stem Cell Res Ther; 2024 Jan; 15(1):1. PubMed ID: 38167219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
